-+ 0.00%
-+ 0.00%
-+ 0.00%

Larimar Therapeutics Chief Medical Officer Russell Clayton Reports Acquisition of $9,999.22 in Common Shares

PUBT·11/18/2026 21:31:27
Listen to the news
Larimar Therapeutics Chief Medical Officer Russell Clayton Reports Acquisition of $9,999.22 in Common Shares
  • Larimar Therapeutics Chief Medical Officer Russell Clayton bought 3,322 shares of common stock at $3.01 each.
  • The purchase increased his directly owned holdings to 74,765 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Larimar Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-467167), on November 18, 2026, and is solely responsible for the information contained therein.